Free Trial
ASX:PAR

Paradigm Biopharmaceuticals (PAR) Stock Price, News & Analysis

Paradigm Biopharmaceuticals logo

About Paradigm Biopharmaceuticals Stock (ASX:PAR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.81 million shs
Average Volume
N/A
Market Capitalization
A$196.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Paradigm Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PAR Stock News Headlines

Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
See More Headlines

PAR Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Paradigm Biopharmaceuticals investors own include BHP Group (BHP), Electro Optic Systems (EOS), Mesoblast (MESO), CytoDyn (CYDY), Bubs Australia (BUB), Blue Energy (BLU) and BHP Group (BHP).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Computer Hardware
Current Symbol
ASX:PAR
CIK
N/A
Fax
N/A
Employees
1,480
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$58.65 million
Net Margins
-89,138.58%
Pretax Margin
N/A
Return on Equity
-203.64%
Return on Assets
-86.16%

Debt

Debt-to-Equity Ratio
1.01
Current Ratio
7.22
Quick Ratio
5.93

Sales & Book Value

Annual Sales
A$79.22 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
6.44
Book Value
A$0.08 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
350,360,000
Free Float
N/A
Market Cap
A$196.66 million
Optionable
Not Optionable
Beta
0.94
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ASX:PAR) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners